论文部分内容阅读
目的:探讨介入治疗先天性心脏病近期临床疗效。方法:对662例先天性心脏病患者,其中单一病变605例,复合病变57例;先天性心脏缺损在经胸彩色超声心动图(TTE)及X线影像指导下,经皮沿导丝经传送鞘管将合适的封堵器至缺损处行封堵;肺动脉瓣狭窄采用Inoue球囊或聚乙烯球囊行肺动脉瓣球囊扩张术。结果:TTE测量房间隔缺损为(16.8±7.6)mm,所用封堵器为(20.3±8.8)mm;左室造影测量室间隔缺损直径为(6.7±3.4)mm,封堵器(8.9±4.2)mm;造影测量动脉导管未闭最窄处直径为(6.6±3.2)mm,所选用封堵器直径为(12.7±4.4)mm;662例先天性心脏病患者中介入成功者627例,35例未成功,成功率94.7%,成功者术后即刻未见明显分流;肺动脉瓣球囊扩张术后跨瓣压差均降至2.66kPa以下。结论:先天性心脏病经皮介入治疗操作简单、成功率高、安全可靠、近期临床疗效好。
Objective: To investigate the short-term clinical efficacy of interventional therapy for congenital heart disease. Methods: A total of 662 congenital heart disease patients, including 605 cases of single lesions and 57 cases of complex lesions. Congenital heart defects under transthoracic echocardiography (TTE) and X-ray imaging were percutaneously delivered along the guide wire Sheath occlusion of the appropriate occluder to the defect line; pulmonary valve stenosis with Inoue balloon or polyethylene balloon pulmonary balloon valvuloplasty. RESULTS: The TTE was (16.8 ± 7.6) mm in atrial septal defect and (20.3 ± 8.8) mm in occluder. The diameter of ventricular septal defect measured by TTE was 6.7 ± 3.4 mm and the occluder was 8.9 ± 4.2 ) mm; the diameter of the patent ductus arteriosus at the narrowest point was (6.6 ± 3.2) mm and the diameter of the occluder selected was (12.7 ± 4.4) mm; 627 cases of 662 congenital heart disease patients were successfully involved Successful cases were 94.7%, successful no immediate shunt after the operation; pulmonary valvuloplasty postoperative transvalvular pressure drop to 2.66kPa below. Conclusion: The percutaneous interventional treatment of congenital heart disease is simple, high success rate, safe and reliable, and has good clinical efficacy recently.